Downregulation of WIF-1 by hypermethylation in astrocytomas

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 6, 2010, Pages 418-425

  Yang, Zhuanyi ^a   Wang, Ying ^b   Fang, Jiasheng ^a   Chen, Fenghua ^a   Liu, Jingfang ^a   Wu, Jun ^a   Wang, Yanjin ^a   Song, Tao ^a   Zeng, Feiyue ^a   Rao, Yihua ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Aastrocytomas; Promoter methylation; Wnt inhibitory factor 1 (WIF 1)

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; BETA CATENIN; DRUG DERIVATIVE; MESSENGER RNA; REPRESSOR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; WIF1 PROTEIN, HUMAN; WNT PROTEIN;

ARTICLE; ASTROCYTOMA; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; ANALOGS AND DERIVATIVES;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ASTROCYTOMA; AZACITIDINE; BETA CATENIN; CELL LINE, TUMOR; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 77952998619     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq037     Document Type: Article

References (28)

1. Wen PY and Kesari S. Malignant astrocytomas in adults. N Engl J Med 2008, 359: 492-507.
2. Pu P, Zhang Z, Kang C, Jiang R, Jia Z, Wang G and Jiang H. Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant astrocytoma cell growth. Cancer Gene Ther 2009, 16: 351-361.
3. Yu JM, Jun ES, Jung JS, Suh SY, Han JY, Kim JY and Kim KW, et al. Role of Wnt5a in the proliferation of human glioblastoma cells. Cancer Lett 2007, 257: 172-181.
4. Sareddy GR, Challa S, Panigrahi M and Babu PP. Wnt/beta-catenin/Tcf signaling pathway activation in malignant progression of rat astrocytomas induced by transplacental N-ethyl-N-nitrosourea exposure. Neurochem Res 2009, 34: 1278-1288.
5. Sareddy GR, Panigrahi M, Challa S, Mahadevan A and Babu PP. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas. Neurochem Int 2009, 55: 307-317.
6. Hsieh JC, Kodjabachian L, Rebbert ML, Rattner A, Smallwood PM, Samos CH and Nusse R, et al. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 1999, 398: 431-436.
7. Ding Z, Qian YB, Zhu LX and Xiong QR. Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma. World J Gastroenterol 2009, 15: 2595-2601.
8. Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I and Reguart N, et al. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res 2004, 64: 4717-4720. (Pubitemid 38924512)
9. Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T and Tanaka Y, et al. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res 2006, 12: 383-391.
10. Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K and Adachi Y, et al. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 2005, 24: 7946-7952.
11. Fuller GN and Scheithauer BW. The 2007 revised World Health Organization (WHO) classification of tumors of the central nervous system: newly codified entities. Brain Pathol 2007, 17: 304-307.
12. Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft SK and Seyfried NT, et al. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 2000, 60: 4926-4931.
13. Reguart N, He B, Xu Z, You L, Lee AY, Mazieres J and Mikami I, et al. Cloning and characterization of the promoter of human Wnt inhibitory factor-1. Biochem Biophys Res Commun 2004, 323: 229-234. (Pubitemid 39200673)
14. Turashvili G, Bouchal J, Burkadze G and Kolar Z. Wnt signaling pathway in mammary gland development and carcinogenesis. Pathobiology 2006, 73: 213-223.
15. Fodde R and Brabletz T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 2007, 19: 150-158.
16. Shiina H, Igawa M, Breault J, Ribeiro-Filho L, Pookot D, Urakami S and Terashima M, et al. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Clin Cancer Res 2003, 9: 2121-2132.
17. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT and Morin PJ, et al. Identification of c-MYC as a target of the APC pathway. Science 1998, 281: 1509-1512.
18. Tetsu O and McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398: 422-426.
19. Kawano Y and Kypta R. Secreted antagonists of the Wnt signaling pathway. J Cell Sci 2003, 116: 2627-2634.
20. Hu YA, Gu X, Liu J, Yang Y, Yan Y and Zhao C. Expression pattern of Wnt inhibitor factor 1 (Wif1) during the development in mouse CNS. Gene Expr Patterns 2008, 8: 515-522.
21. Peng D, Ren CP, Yi HM, Zhou L, Yang XY, Li H and Yao KT. Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma. Acta Biochim Biophys Sin 2006, 38: 349-355.
22. Herman JG and Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349: 2042-2054.
23. Vladimirova V, Mikeska T, Waha A, Soerensen N, Xu J, Reynolds PC and Pietsch T. Aberrant methylation and reduced expression of LHX9 in malignant astrocytomas of childhood. Neoplasia 2009, 11: 700-711.
24. Blanc JL, Wager M, Guilhot J, Kusy S, Bataille B, Chantereau T and Lapierre F, et al. Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas. J Neurooncol 2004, 68: 275-283.
25. Schmidt EE, Ichimura K, Messerle KR, Goike HM and Collins VP. Infrequent methylation of CDKN2A (MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumors. Br J Cancer 1997, 75: 2-8.
26. Wiencke JK, Zheng S, Jelluma N, Tihan T, Vandenberg S, Tamguney T and Baumber R, et al. Methylation of the PTEN promoter defines low-grade astrocytomas and secondary glioblastoma. Neuron Oncol 2007, 9: 271-279.
27. Wemmert S, Bettscheider M, Alt S, Ketter R, Kammers K, Feiden W and Steudel WI, et al. p15 promoter methylation-a novel prognostic marker in glioblastoma patients. Int J Oncol 2009, 34: 1743-1748.
28. Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M and Kristiansen G, et al. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol 2003, 201: 204-212.